Articles tagged with Stem Cell Research
New research suggests neural crest cells retain adaptability even after differentiation, enabling them to 'change their mind' and differentiate anew. This hyper-flexibility has significant implications for regenerative medicine, as these cells have immense potential as treatments to replace and repair damaged body tissue.
Cedars-Sinai investigators have discovered a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using human induced pluripotent stem cells. The new approach uses cells derived from iPSCs that are renewable, scalable, and can delay disease progression in rodents.
Researchers at The Mount Sinai Hospital have created versatile disease models of acute myeloid leukemia (AML), allowing for accurate study of the cancer's progression and response to drugs. These models, derived from induced pluripotent stem cells, can mimic different stages of AML and are nearly identical to those found in patients.
Cedars-Sinai Medical Center is launching a historic Ax-2 mission that aims to produce induced pluripotent stem cells in microgravity for the first time. The upcoming mission will utilize astronauts to generate these stem cells, paving the way for potential treatments and research opportunities.
Researchers used prime editing to correct the mutation that causes sickle cell disease, restoring normal blood parameters in mice. The approach showed promising results with up to 41% conversion of mutated cells to healthy ones.
Researchers developed a novel approach that promotes bone regeneration in mice without implantation of bone tissue or biomaterials. By carefully stretching the skull along its sutures, they activated skeletal stem cells that reside in these wiggly seams, repairing damage to the skull that would not have healed on its own.
Researchers at Duke-NUS Medical School have achieved significant vision recovery in experimental models of damaged retinas using stem cells. The study marks a promising step towards potentially restoring vision in eye diseases characterized by photoreceptor loss.
Researchers have developed a new technology to sequence individual mitochondria in single cells, allowing for unbiased analysis of full-length mtDNA. This has revealed complex patterns of pathogenic mtDNA mutations and the potential risks of off-target mutations in genetic editing strategies.
Researchers at Vanderbilt University Medical Center have discovered a new way to measure the growth rate of precancerous clones of blood stem cells using a technique called PACER. The findings suggest that drugs targeting the gene TCL1A may be able to suppress clonal growth and associated cancers.
A study found that cell competition between neural progenitor cells regulates brain size in mice, with top performers producing 30%-40% of neurons and losers producing only 1%-2%. The researchers identified Axin2 and p53 as key drivers of this process.
Researchers created the integrated-gut-liver-on-a-chip platform to examine how gut and liver cells interact, particularly in relation to non-alcoholic fatty liver disease. The study showed significant changes in gene expression and DNA damage when free fatty acids were introduced, leading to cell death similar to severe cases of NAFLD.
Researchers at Trinity College Dublin have discovered a new process that explains why cells have unique identities. By studying Polycomb protein complexes, the team found that different forms of these proteins recruit distinct complexes to DNA, shedding light on cellular identity and its potential impact on cancer treatments.
Researchers at the University of Washington School Medicine have engineered stem cells that do not generate dangerous arrhythmias. These 'MEDUSA' cardiomyocytes can engraft in the heart, mature into adult cells and beat in sync with natural pacemaking without generating dangerous heart rates.
A team of investigators created embryo-like structures from monkey embryonic stem cells and transferred them into female monkeys, which implanted and elicited a hormonal response similar to pregnancy. The study provides new tools and perspectives for exploring primate embryos and reproductive medical health.
A study by Linköping University researchers found that blood stem cells from leukemia patients remain in the bone marrow, but become defective over time, leading to long-term effects on blood formation. This discovery may explain why many leukemia survivors experience blood cell function disorders later in life.
Researchers have identified a promising new combination of drugs to treat juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer affecting children. The combination of 5-azacitidine and MEK inhibitor PD0325901 reduced cancerous stem cells and improved blood cell abnormalities.
Researchers at TUM have developed a method to create mini-hearts in Petri dishes using stem cells. The resulting organoids mimic the earliest stages of human heart development and can be used to investigate congenital heart defects, potentially leading to new treatment methods.
Researchers at the University of Missouri have developed a process for marking transplanted donor bone marrow cells, allowing them to target only cancerous cells. This breakthrough offers new hope for bone marrow transplant patients with blood cancers such as lymphoma and leukemia.
Researchers discover ZBTB12, a molecular barrier that prevents dedifferentiation in human pluripotent stem cells, and shed light on the core differentiation mechanism.
Scientists at the University of Helsinki have discovered that genetic mutations can significantly impact the accuracy of stem cell-based disease models. The researchers found that somatic mutations in genes like BCOR can affect the differentiation process and gene expression, leading to variations in the model's reliability.
Researchers at the Francis Crick Institute have discovered a key role for autophagy in controlling intracellular infections like TB. By boosting this natural process, they hope to create new treatments that can combat antibiotic-resistant bacteria.
The study successfully generated functional patient-specific T-cells and thymic epithelial cells from human pluripotent stem cells using thymus organoids. This breakthrough provides a new experimental model system to investigate thymic insufficiency and function, potentially leading to cell-based treatments for thymic defects.
Scientists from USC Stem Cell laboratory discovered a mechanism linking leukemic mutations to varying disease potentials, identifying RNA splicing regulator Rbm25 as a critical factor. The study found that over-contributing clones of blood stem cells produce excessive myeloid cells, leading to potential leukemia development.
Researchers discovered that mechanical loading can exacerbate inflammation in aged muscles, hindering healing. However, combining mechanotherapy with anti-inflammatory treatment significantly improves healing in aged muscles.
Researchers have found a potential treatment for osteoarthritis by targeting the GP130 immune receptor, which causes hyper-inflammation in joints. The new compound R805/CX-011 showed promising results in animal studies, reducing joint pain and stiffness, and may lead to Phase 1 and 2A clinical trials.
Researchers developed a neural implant that restored limb function to amputees and paralysed individuals by integrating with the brain and nerve. The biohybrid device combines electronic components with reprogrammed muscle cells, preventing scar tissue formation and improving signal extraction.
Researchers found that hematopoietic stem cells use aggrephagy to collect and destroy misfolded proteins, a process that is critical for maintaining stem cell fitness and longevity. Boosting this pathway could help preserve stem cell health and mitigate blood and immune disorders.
Researchers identified key Hox genes as controllers of stem cells involved in both forming and repairing bone. Increasing the activity of these genes restored fracture repair capacity in aging mice by 32.5%, highlighting their potential for treating bone-healing deficiencies.
Researchers at UCLA successfully used base editing to correct a mutation causing rare immune deficiency CD3 delta SCID. The treatment corrected an average of 71% of patient stem cells and allowed them to produce fully functional T cells, suggesting long-term persistence of corrected blood stem cells.
Researchers at German Cancer Research Center have developed a marker that predicts which patients with acute myeloid leukemia (AML) will respond to the new therapy. The marker, known as the MAC score, measures the ratio of specific proteins in leukemia stem cells and can be used to determine treatment success.
Researchers from the Wellcome Sanger Institute have established a system to report CRISPR activation effectiveness in stem cells, revealing key features influencing its efficiency. The study found that bivalent genes can be robustly activated by CRISPRa and that cell state and gene location impact its success.
A new coating material developed by Korean researchers facilitates bone regeneration and attracts osteo-progenitor cells, significantly improving the success rate of dental implants. The coating, loaded with BMP-2, prevents non-osteogenic cell invasion and induces high bone differentiation in a short period.
Researchers at University of Technology Sydney have successfully created personalized 'bio-inks' from patients' own stem cells, which are then used to 3D-print cardiac tissues to repair areas of dead tissue. This technology shows promise in treating heart failure and may reduce the need for expensive and traumatic heart transplants.
A USC-led team of scientists identified the key gene Nr5a2, essential for opening up genome regions that enable neural crest cells to form tendons and salivary glands. Zebrafish and mice lacking this gene exhibited skeletal and tendon defects, as well as failed salivary gland development.
Two compounds, A5 and C1, have shown promising results in inhibiting the growth of glioblastoma cells, a type of aggressive brain cancer. Further research is needed to confirm their effectiveness on normal nerve cells and to move towards clinical trials.
Researchers at Mayo Clinic found that a dissolvable plug delivering stem cells can heal single-tract fistulas in patients with Crohn's disease. The treatment has shown durable results with minimal side effects, offering hope for patients with refractory perianal fistulas.
A recent study led by Murdoch Children's Research Institute has revealed a new pathway for how genetic mutations impact heart muscle function. The research identifies the gene ALPK3 as a key player in cardiomyopathy, a group of diseases affecting the heart's ability to pump blood, and provides hope for new targeted therapies.
A new cell therapy has demonstrated significant benefits in improving the heart's pumping ability and reducing the risk of cardiovascular death, heart attack, or stroke in patients with chronic heart failure. The therapy, using mesenchymal precursor cells (MPCs), also showed a strong signal in reducing inflammation and improving microv...
Researchers have developed a new 'hybrid' hydrogel that safely delivers stem cells to damaged brain tissue, repairing injuries in mice. The breakthrough solves a long-standing challenge and paves the way for potential treatments beyond the brain.
Scientists have successfully transformed blood cells into sperm precursors in marmoset embryos using a step-by-step process. The study, published in eLife, opens up new avenues for studying primate biology and developing novel assisted reproductive technologies.
Researchers have generated induced pluripotent stem cells from bats, gaining insights into the relationship between bats and viruses. The study may also shed light on bats' remarkable defenses against aging and cancer.
A 53-year-old man has been cured of HIV after receiving a stem cell transplant, marking the third person to achieve this. The patient's genome contained a mutation in the CCR5 gene, making it impossible for most HIV viruses to enter his CD4+ T-lymphocytes.
Researchers have successfully converted pluripotent stem cells into hematopoietic stem and progenitor cells using optimized transcription factors. The resulting PSC-derived cells generated all types of white blood cells in mice without giving rise to tumors or leukemias, suggesting a promising future for PSC-based transplant therapies.
Researchers have generated large-scale muscle-controlling nerve cells from ALS patients, revealing striking differences in gene expression between males and females. The study, published in Neuron, used over 450 lines of stem cells to create motor neurons that can potentially lead to the development of new therapeutics.
Researchers at USC Keck School of Medicine have identified two new avenues for treating diverse forms of ALS by suppressing genes and inhibiting proteins. The findings suggest that targeting SYF2 gene suppression and PIKFYVE kinase inhibition may lead to broadly effective treatments for the disease.
Scientists made a groundbreaking discovery that lymphatic vessels can produce both red and white blood cells, challenging the long-held belief that blood cells come solely from bone marrow. The study suggests that lymphatic vessels may play a role in fighting infection and could be important for treating certain blood cancers.
Researchers successfully transplanted human brain organoids into adult rat brains and observed functional integration, including response to visual stimulation. The study demonstrates potential for neural tissues to rebuild injured brain areas.
The ISSCR 2023 Annual Meeting will showcase the year's most compelling stem cell research and clinical breakthroughs. Attendees can participate in dedicated poster sessions and interact with presenters.
Researchers generated cochlear avatars from stem cells, recreating hair cell function and transmitting electrical signals. This breakthrough enables the investigation of sensorineural hearing loss mechanisms and potential treatments.
Leif Ludwig's analytical method allows for easier disentanglement of blood cell trajectories, enabling identification of leukemia cell development or degenerative changes. This breakthrough opens up possibility for human medicine to conduct studies in clinical practice and derive therapeutic interventions.
Researchers at Children's Hospital of Philadelphia have developed a custom-built application to automate the determination of engraftment after hematopoietic stem cell transplant. The tool has been shown to improve accuracy of reported engraftments, reducing errors in neutrophil and platelet engraftment reporting.
Researchers found a link between astrocytes from schizophrenic patients and reduced vascularization in the brain, which may contribute to the disease's metabolic flux. The study suggests that astrocytes could be a target for novel therapies to address schizophrenia.
A team of researchers from Korea and USA identified the importance of lipid homeostasis in overcoming brain cancer radioresistance. They found that regulating diacylglycerol kinase B and diacylglycerol acyltransferase 1 could potentially sensitize brain cancer cells to radiotherapy, offering a new treatment strategy.
Researchers identified 17 clusters of single cells in peripheral blood, showing upregulation of antigen processing and presentation pathways and downregulation of genes involved in ribosome pathways with age. The study also found senescent T cells resistant to apoptosis, potentially targeted for treatment.
Researchers have discovered a biological pathway that governs the life and death of stem cells, which may lead to new treatments for cancer and regenerative therapies. By manipulating cell signaling, scientists can normalize the creation of new cells, preventing excessive growth and ensuring proper tissue regeneration.
Researchers have discovered that more than 2,500 genes exhibit significant sex differences in expression in mouse alveolar type II cells, potentially explaining sex biases in lung diseases. These findings suggest that AT2 cells may play a crucial role in sex-biased differences in lung injury and repair.
Ceramides accumulate in aged muscle, impairing its function and affecting functional capacity in older adults. This finding encourages researchers to develop potential pharmaceutical agents to combat sarcopenia and age-related diseases.
Engineers create OCTOPUS device to grow organs-in-a-dish, achieving higher levels of maturity than traditional methods. The device allows for more mature organs with complex cell relationships, providing valuable tools for studying human organ development.
Researchers have successfully grown retinal cells from stem cells that can connect with neighboring cells and transmit sensory information like healthy ones. The breakthrough could lead to human clinical trials to treat degenerative eye disorders such as retinitis pigmentosa and age-related macular degeneration.
A new stem cell model allows researchers to study the earliest stages of sex determination in mice and humans, providing insights into Disorders of Sex Development (DSD). The model enables the creation of a 'mini testis' in a dish, which could lead to better understanding of DSD, infertility, and fertility restoration.